Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt in Normal Tension Glaucoma
NCT00832377Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of timolol, dorzolamide in normal tension glaucoma (NTG), sponsored by Merck & Co.. Started Apr 2009; status: completed.
02
Drugs
timololdorzolamide
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT00832377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832377.